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Summary
Introduction.—Osteonecrosis of the femoral head (ONFH) is a frequent complication of sickle-
cell disease. Numerous studies have demonstrated increased intraosseous pressure (IOP) in
idiopathic necrosis and necrosis secondary to corticotherapy or alcohol poisoning. Several
reports have testiﬁed to the clinical interest of decompression by drilling which, when per-
formed in the early course of the pathology, can arrest or slow evolution. To the best of our
knowledge, no studies have reported IOP increase in sickle-cell ONFH. The present study sought
to show that intraosseous hyperpressure plays a role in the physiopathology of sickle-cell, like
idiopathic, ONFH.
Materials and methods.— Sixteen intraosseous pressure (IOP) measurements were taken: eight
in adult sickle-cell disease patients, four in sickle-cell trait carrying ONFH patients (AS) and
four in non-sickle-cell ONFH patients (AA).
Arterial blood-pressure equipment with bone-puncture needle was used to measure IOP in
the great trochanter body. Three IOP measurements were made after zero calibration: before
drilling (direct pressure: IOP-1), after hyperpressure test but before drilling (IOP-2), and after
drilling (IOP-3).
Results.—The present, admittedly short, series displayed elevated predrilling IOP-1 and IOP-2,
reduced after drilling (IOP-3). Abnormal IOP fell after drilling performed for evolutive symp-
tomatic ONFH. Signiﬁcant differences in IOP-1 and IOP-2 were found, these being higher in the
‘‘sickle-cell disease’’ and ‘‘sickle-cell trait carriers’’ groups (p < 0.05). Only in the sickle-cell
groups was there a signiﬁcant correlation between pain score and hyperpressure level, with
signiﬁcantly reduced pain after drilling.
Discussion.—The elevated IOP levels found in symptomatic sickle-cell hips were comparable to
those reported in the literature. Ischemia due to femoral head sinusoid occlusion by falciform
globules with secondary intraosseous hyperpressure is the cause of the pain and of the onset
and evolution of ONFH. The drilling tunnel acts as a safety valve, achieving real decompression
of the segment involved and immediate postoperative reduction in or disappearance of pain.
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available. It can be carried out very straightforwardly, without pressure sensor, using a simple
water column (physiological saline) and three-way tap. Peroperative comparison of IOP-1 and
IOP-3 is a means of assessing the effectiveness of decompression drilling.
© 2009 Elsevier Masson SAS. All rights reserved.
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oIntroduction
Osteonecrosis of the femoral head (ONFH) is a frequent
complication of sickle-cell disease, with an incidence
estimated at 30—40% [1—7]. The literature contains
no reports of hyperpression in sickle-cell-disease-related
ONFH, although it could explain the severe pain associ-
ated with vaso-occlusion episodes. Bone decompression is
the key to cessation of pain and favorable evolution of
infarction and osteomyelitis lesions [8]. The present study
seeks to demonstrate that hyperpression is at work in
sickle-cell-disease-related ONFH, and the interest of early
decompression drilling (Fig. 1).
Material and methods
Patients
Ten patients aged between 18 and 50 years, presenting
with grade I, II or III uni- or bilateral ONFH (grade III
being deﬁned by subchondral dissection without loss of
sphericality) underwent decompression drilling and pres-
sure measurement in the Pointe-à-Pitre teaching hospital in
Guadeloupe between October 2000 and December 2006. Six
were sickle-cell patients (3 SS, 3 SC; 8 hips), two were sickle-
cell trait carriers with ONFH (AS; 4 hips) and two were ONFH
patients free of sickle-cell disease (AA; 4 hips). The classiﬁ-
cation used was that of Arlet et al. [9], adapted for modern
imaging by ARCO [10].
Figure 1 IOP needle position in great trochanter body and
drill position in femoral head.
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tSixteen intraosseous pressure (IOP) measurements were
aken: eight on adult homozygotic sickle-cell disease
atients, four on necrotic hips in sickle-cell trait carriers
generally considered to be free of risk of severe complica-
ion, but in whom necrosis has nevertheless been reported
n some rare cases) [11], and four on necrotic hips in sickle-
ell-free patients. Ethical considerations precluded using
he contralateral hip of the same patient as control [12].
Clinically, the patients presented with hip pain, limp-
ng and movement impaired by pain on rotation, especially
nternal. Pain intensity was assessed, before and after
rilling, on a 0—100 numeric assessment scale, the patient
etting a marker between the two extremes according to the
ntensity of pain experienced at a given time [13]. Sickle-cell
isease patients are hyperalgesic, making pain assessment
ifﬁcult due to under- or overestimation. Subjective esti-
ation was therefore backed up by taking account of three
egrees of analgesics consumption (I, IIa/b, III), with inten-
ity thus classiﬁed as: 0 ‘‘no pain’’, 0—50 ‘‘moderate pain’’
elieved by I or IIa analgesics (non- or low morphine),
nd > 50 ‘‘intense pain’’ relieved by IIb or III analgesics
medium or high morphine) [14]. Pre- and postdrilling pain
cores (PSpre and PSpost, respectively) were recorded. Diag-
ostic imaging (standard X-ray, CT and MRI) determined the
steonecrosis grade, following Arlet et al. [9].
OP measurement
he technique, based on Arlet et al. [9], was simple and
dapted to sickle-cell disease patients, who are fragile
nder anesthesia [15,16]. Taking our lead from intraosseous
erfusion techniques, we employed a Jamishidi DJ4008X
uncture needle, 8G× 10 cm [17]. Pressure was measured
nder visual control before and after decompression drilling
f the femoral head. Measurement was feasible only in
he great trochanter body (Fig. 1), by direct puncture
cm under the tip of the greater trochanter after per-
oration by a thin square-tipped awl and introduction of
bone-puncture needle connected up to a pressure sen-
or by a sterile tube ﬁlled with physiological saline. The
atient was installed in dorsal decubitus, with the sen-
or at heart-level on the midaxillary line. The ﬁnal value
fter stabilizing the mean IOP curve was read directly fromSickle-cell hip necrosis and intraosseous pressure 135
Conclusion.— Measuring pressure is of diagnostic interest in sickle-cell disease patients with
symptomatic hips. Manometry can be performed independently of surgery, under local anesthe-
sia, and provides early conﬁrmation of ONFH in geographic regions in which MRI is not readilyhe anesthesia ECG monitor. Correct cancellous position-
ng of the needle was conﬁrmed by regular pressure-curve
ariation synchronized to the heartbeat. Direct measure-
ent was followed up by an evoked hyperpressure test
intraosseous injection of 5ml heparinized saline into the
rochanter) to disclose any infraclinical pathology unde-
ectable at baseline. Three measurements were made per
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Table 1 IOP (mm/Hg) sickle cell patients (SS, SC).
Patient/side Type Age Age grade IOP1 IOP2 IOP3 IOP2-IOP1 IOP1-IOP3 IOP2-IOP3
1L SS 34 I 49 55 26 6 23 29
2R SC 27 II 79 101 49 22 30 52
2L SC 27 III 87 103 55 16 32 48
3L SC 27 III 87 103 55 16 32 48
4L SS 18 III 77 91 42 14 35 49
5L SC 22 III 78 82 50 4 28 32
6L SC 28 III 38 49 27 11 11 22
6R SC 28 III 82 90 34 8 48 56
Mean 72± 15 84± 18 42± 10 12,1 29.9 42
Signiﬁcance: IOP1-IOP3, t = 7.98 (p < 0.001); IOP2-IOP1, t = 5.65 (p < 0.001); IOP2-IOP3, t = 9.44 (p < 0.001).
Table 2 IOP (mm/Hg) sickle-cell trait patients (AS).
Patient/side Type Age Arlet grade IOP1 IOP2 IOP3 IOP2-IOP1 IOP1-IOP3 IOP2-IOP3
1L AS 50 II 98 102 41 4 57 61
1R AS 50 II 96 100 45 4 51 55
2L AS 50 II 80 113 49 33 31 64
2R AS 50 II 72 88 35 16 37 53
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Signiﬁcance: IOP1-IOP3, t = 7.30 (p < 0.01); IOP2-IOP1, t = 2.07 (NS
ip: two before drilling (1 direct, IOP-1; one following the
yperpressure test, IOP-2), and one after core decompres-
ion (IOP-3).
tatistics
yperpressure was studied according to genetic group
y comparison of means for small-sample paired series,
sing Schwartz’s formula [18]: t =m/s/N½, where t is read
rom Fisher and Yates’ table (DOF =N—1; Tables 1—4).
eries 1 and 2 (sickle-cell disease SS and SC, or carrier
S) taken together were compared to series 3 (AA) by
he formula: (MA —MB)/(S2/NA + S2/NB)½, where S2 stands
or variance, taken as common (Tables 1 and 2). Pain
core (PSpre minus PSpost, equaling 1 or 2) accord-
ng to the difference between IOP-2 and IOP-3 was
ssessed by the same formula with variance calculated as
2 = [
∑
(x—mA)2 +
∑
(x—mB)2]/(nA + nB — 2)].
c
c
u
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Table 3 IOP (mm/Hg) non-sickle cell patients (AA).
Patient/side Type Age Arlet grade IOP1 IO
1L AA 33 II 40 62
1R AA 33 II 56 65
2L AA 34 II 59 61
2R AA 34 II 53 61
Mean 52± 13 62
Signiﬁcance: IOP1-IOP3, t = 5.22 (p < 0.02); IOP2-IOP1, t = 2.43 (NS); IOP± 16 43± 9 14.3 44 58.3
2-IOP3, t = 22.6 (p < 0.001).
esults
he 16 IOP measurements (Tables 1—3) showed elevation
ssociated with both idiopathic and sickle-cell ONFH, and
eduction following decompression drilling.
The study lacked power to disclose any difference in IOP
alues between the three series. Comparing series 1 and 2
sickle-cell disease SS and SC, and carrier AS, respectively)
aken together to series 3 (idiopathic necrosis) disclosed a
igniﬁcant difference for IOP-1 and IOP-2, which were higher
n sickle-cell disease patients and trait carriers (p < 0.05),
ut not for IOP-3 (postdrilling).
Comparing degree of hyperpression according to pain
ntensity as per Schwartz [18] showed no correlation
or all patients and genotypes taken together. In sickle-
ell disease patients and trait carriers (12 hips), in
ontrast, pain was reduced in nine hips (75%) and
nchanged in three (25%, NS, p = 0.0833), and the pres-
ure difference before and after drilling (IOP-2 minus
OP-3) was 44.4± 9mm/Hg for the nine hips showing
P2 IOP3 IOP2-IOP1 IOP1-IOP3 IOP2-IOP3
28 22 12 34
27 9 29 38
34 2 25 27
37 8 16 24
± 3 32± 15 10.3 20.5 30.8
2-IOP3, t = 9.61 (p < 0.001).
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relief, and 56.3± 7.7 for the other three (no change)
(p < 0.005).
Discussion
Larsen [19] and Miles [20] demonstrated the ischemic impact
of intraosseous hyperpressure in the physiopathology of
necrosis of the femoral head. The elevated IOP values
found here in pathological hips of sickle-cell disease patients
are comparable to those in the literature [9,21—24]. IOP-1
and IOP-2 were higher homozygotic (SS) and double het-
erozygotic (SC) sickle-cell subjects with necrosis than in
sickle-cell-free (AA) patients. Our results support Ratcliff
et al.’s contention [11] that bone abnormality is found in
heterozygotic (AS) subjects, even if more rarely.
IOP was measured by a manometer in mm/Hg. It can
be measured in two parts of the hip: femoral head and
trochanter body, values taken in the former being 5mm/Hg
than in the greater trochanter [9]. Normal values do not
exceed 30mm/Hg (24mm for Ficat et Arlet [22], and 26mm
for Kiaer et al. [24]). Values above 30mm/Hg are consid-
ered pathological [9,23]. Arlet et al. [9] provided reference
values for IOP in the superior femoral epiphysis of adults
with and without hip necrosis. IOP-3 fell signiﬁcantly with
decompression drilling, without, however, always passing
the 30mm/Hg threshold in sickle-cell disease (SS, SC) or
trait-carrying (AS) patients.
Like Hauzeur et al. [23], reporting idiopathic ONFH, we
found no correlation between degree of hyperpressure and
sickle-cell-disease-related ONFH grade (Tables 1 and 2).
Likewise, drilling produced an analgesic effect, with reduc-
tion or cessation of pain. The drilling hole is open after
puncture/ablation of the osseous core and acts as an out-
let, providing real decompression of the treated segment.
It promotes conjunctive tissue colonization and thus revas-
cularization of the femoral head by peritrochanter vessels
— the neovascular interpretation of necrotic bone-lesion
repair put forward by Arlet et al. [9], which is compatible
with the concept of cell repair by addition of bone marrow
with drilling, as proposed by Hernigou et al. [25].
Initial necrosis cannot be seen on X-ray and can only be
diagnosed on MRI; while the latter may be feasible in many
countries, sickle-cell disease prevails in populations who
have no such access. X-ray and clinical evolution indicates
that early decompression drilling in clinical ONFH prevents
necrosis developing into disabling osteoarthritis.
Conclusion
Pressure measurement is of diagnostic value in sickle-cell
patients presenting with a symptomatic hip. Independently
of surgery, manometry can be performed under local anes-
thesia to conﬁrm early diagnosis of ONFH where MRI is not
readily available. It can be performed quite straightfor-
wardly, without pressure sensor, using a simple water column
(physiological saline) and a three-way tap. The effective-
ness of decompression drilling can thereby be assessed by
comparing peroperative IOP-1 and IOP-3 values.
X-ray and clinical evolution indicates that early decom-
pression drilling in ONFH prevents necrosis developing into
disabling arthroscopic lesions. Patients experience deﬁnite
[
[137
ip pain reduction immediately after drilling. All reports
oncur on this. Decompression drilling in sickle-cell-disease-
elated necrosis serves two purposes: bone decompression
ith pain reduction after drilling in ONFH, and arresting the
schemic process before the femoral head loses sphericality
r sequelae ensue from acute bone infarction.
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